Atlas Biolabs

Executive Summary

Atlas Biolabs is a German contract research organization (CRO) based in Berlin, founded in 2014, that provides comprehensive molecular genetic and bioinformatics services. The company specializes in next-generation sequencing (NGS), microarray analyses, proteomics, and microbiome sequencing, serving academic, clinical, and industrial clients. As a private entity with no disclosed funding or valuation, Atlas Biolabs operates in the competitive CRO market, focusing on quality and breadth of service offerings. Its position in the growing genomics and diagnostics sectors positions it for steady demand, though scalability depends on continued investment and client acquisition.

Upcoming Catalysts (preview)

• Q2 2026Expansion of Service Offerings or New Technology Platform Launch70% success
• Q3 2026Strategic Partnership with Pharmaceutical or Biotech Company50% success
• Q1 2027Laboratory Capacity Expansion or Relocation to Larger Facility40% success